Key result
Meis1 overexpression shortens QRS duration by ~19% and reduces ventricular arrhythmias in post-MI mice.
Why the study?
The functions of the transcription factor Meis1 in ischemic arrhythmias following myocardial infarction were largely undefined.
Does Meis1 overexpression reduce ischemic arrhythmias and improve cardiac conduction in post-MI mice?
Does Meis1 overexpression reduce ischemic arrhythmias and improve cardiac conduction in post-MI mice?
Meis1 overexpression rescues NaV1.5 dysregulation and improves cardiac electrical conduction in post-infarct mice, revealing a novel mechanism and potential therapeutic target for ischemic arrhythmias.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for Meis1-targeted therapy in post-MI arrhythmias; requires validation before any clinical consideration.
The principal voltage-gated Na+ channel, NaV1.5 governs heart excitability and conduction. NaV1.5 dysregulation is responsible for ventricular arrhythmias and subsequent sudden cardiac death (SCD) in post-infarct hearts. The transcription factor Meis1 performs a significant role in determining differentiation fate and regenerative capability of cardiomyocytes. However, the functions of Meis1 in ischemic arrhythmias following myocardial infarction (MI) are still largely undefined. Here we aimed to study whether Meis1 could act as a key regulator to mediate cardiac Na+ channel and its underlying mechanisms. Heart-specific Meis1 overexpression was established by AAV9 virus injection in C57BL/6 mice. The QRS duration, the incidence of ventricular arrhythmias and cardiac conduction velocity were evaluated by ECG, programmed electrical stimulation and optical mapping techniques respectively. The conventional patch clamp technique was performed to explore the INa characteristics of isolated mouse ventricular myocytes. In vitro, Meis1 was also overexpressed in hypoxic-treated neonatal cardiomyocytes. The analysis of immunoblotting and immunofluorescence were used to detect the changes in the expression of NaV1.5 in each group. We found that forced expression of Meis1 rescued the prolongation of QRS complex, produced anti-arrhythmic activity and improved epicardial conduction velocity in infarcted mouse hearts. In terms of mechanisms, cardiac electrophysiological changes of MI mice can be ameliorated by the recovery of Meis1, which is characterized by the restoration of INa current density and NaV1.5 expression level of cardiomyocytes in the marginal zone of MI mouse hearts. Furthermore, in vitro studies showed that Meis1 was also able to rescue hypoxia-induced decreased expression and dysfunction of NaV1.5 in ventricular myocytes. We further revealed that E3 ubiquitin ligase CDC20 led to the ubiquitination and degradation of Meis1, which blocked the transcriptional regulation of SCN5A by Meis1 and ultimately led to the electrophysiological remodeling in ischemic-hypoxic cardiomyocytes. CDC20 mediates ubiquitination of Meis1 to govern the transcription of SCN5A and cardiac electrical conduction in mouse cardiomyocytes. This finding uncovers a new mechanism of NaV1.5 dysregulation in infarcted heart, and provides new therapeutic strategies for malignant arrhythmias and sudden cardiac death following MI.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) studied Myocardial infarction and ischemic arrhythmias. AAV9-Meis1 (Meis1 overexpression) vs. AAV9-NC (Control vector) or Sham was evaluated on QRS duration (ms) (p=<0.01). Forced overexpression of Meis1 significantly shortened QRS duration from 16.4 ms to 13.3 ms and reduced the incidence of ventricular arrhythmias in mice after myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: